Table 2.

Case-based description of underlying diseases, target lesions, implantation data, results, and complications.

Case	Sex	Age (y)	Weight (kg)	Underlying disease	Univentricular heart	Cavo-pulmonary connection (PCPC/TCPC)	Target lesion	Number of implanted AVP ( n )	AVP type	AVP diameter (mm)	Target diameter (mm)	AVP oversizing (%)	Primary (sub-)total occlusion	Complication
1	m	0.67	5.5	HLHS	Yes	PCPC	SPCA	1	2	8	5.1	56	Yes	No
2	f	1.92	12	PA, VSD	No	No	SPCA	2	2 2	4 6	2.6 3.4	53 76	Yes Yes	No
3	m	0.42	8	Prematurity	No	No	SPCA	1	4	4	2.8	42	Yes	No
4	f	28.0	50	DORV, TGA	Yes	TCPC	SPCA	1	4	7	4.3	62	Yes	No
5	f	13.0	31	DILV, TGA	Yes	TCPC	SPCA	1	2	8	5.9	35	Yes	No
6	f	11.42	32	PA, VSD	No	No	SPCA	2	2 4	8 7	4.8 4.8	66 45	No Yes	No
7	m	3.33	14	Unbalanced AVSD	Yes	PCPC	SPCA	2	2 4	8 4	4.0 2.5	50 60	Yes No	No
8	m	20.0	47	DILV, TGA	Yes	TCPC	SPCA	1	2	8	3.9	105	Yes	No
9	f	3.33	13	PA, VSD	No	No	SPCA	1	2	8	4.1	95	Yes	No
10	m	4.67	17	HLHS	Yes	TCPC	SPCA	1	2	4	2.8	42	Yes	No
11	m	17.0	49	PA	Yes	TCPC	SPCA	1	2	8	3.4	135	Yes	No
12	m	1.25	8	HLHS	Yes	No	SPCA	1	4	6	4.1	42	Yes	No
13	m	1.0	9	d-TGA	No	No	SPCA	1	4	6	2.4	150	Yes	No
14	m	4.33	13	HLHS	Yes	PCPC	SPCA	3	2 2 4	8 10 4	3.9 5.0 2.9	105 100 27	Yes Yes No	No
15	f	3.83	13	DORV	Yes	PCPC	SPCA	2	4 4	5 6	2.8 3.2	78 87	No Yes	No
16	f	0.83	6	Prematurity	No	No	PDA	1	2	8	5.2	53	Yes	No
17	f	0.5	6	Prematurity	No	No	PDA	1	2	6	4.8	25	Yes	No
18	m	0.58	6	Prematurity	No	No	PDA	1	2	8	4.7	70	Yes	No
19	m	1.25	7.5	No	No	No	PDA	1	2	6	4.0	50	Yes	No
20	f	0.25	3.1	Prematurity	No	No	PDA	1	2	8	4.3	86	Yes	Yes†
21	m	1.67	10.5	No	No	No	PDA	1	2	8	5.6	42	Yes	No
22	m	1.08	10.6	Prematurity; PAH	No	No	PDA	1	2	8	5.7	40	Yes	No
23	f	3.0	13	No	No	No	PDA	1	2	10	6.0	66	Yes	No
24	m	9.0	25	No	No	No	PDA	1	2	10	8.3	20	No§	No
25	f	10.0	24.5	No	No	No	pVSD	1	2	8	4	100	Yes	No
26	m	2.5	10	Ebstein anomaly, LV noncompaction	No	No	mVSD	1	2	8	5.5	45	Yes	No
27	m	7.67	30	No	No	No	mVSD	1	2	12	8.9	34	Yes	No
28	m	14.92	51	No	No	No	pVSD	1	2	8	7.0	14	Yes	No
29	m	1.5	9	DORV, TGA, Nikaidoh procedure	No	No	mVSD	1	2	8	5.4	48	Yes	No
30	f	10.0	52	Multiple mVSD	No	No	mVSD	1	2	16	9.1	75	Yes	No
31	m	11.25	32	No	No	No	pVSD	1	2	8	7.0	14	Yes	No
32	f	3.75	16	No	No	No	mVSD	1	2	8	5.0	60	Yes	No
33	m	17.5	61	Residual VSD after surgical closure	No	No	pVSD	1	2	10	8.4	19	Yes	No
34	f	42.0	56	Scimitar syndrome, dextrocardia	No	No	PSA	1	2	8	3.6	122	Yes	No
35	f	10.25	26	Scimitar syndrome	No	No	PSA	2	2 4	4 7	n.a.	n.a.	No¥	No
36	m	0.04	3.7	Scimitar syndrome	No	No	PSA	1	2	6	3.9	53	Yes	No
37	f	0.42	6	Scimitar syndrome	No	No	PSA	1	2	8	5.6	42	Yes	No

Abbreviations: AVP = Amplatzer™ Vascular Plug; AVSD = atrioventricular septal defect; DILV = double inlet left ventricle; DORV = double outlet right ventricle; HLHS = hypoplastic left heart syndrome; LV = left ventricle; mVSD = muscular ventricular septal defect; n.a. = not available; PA = pulmonary atresia; PAH = pulmonary arterial hypertension; PCPC= partial cavo-pulmonary connection; PDA = patent ductus arteriosus; PSA = pulmonary sequestration artery; pVSD = perimembranous ventricular septal defect; SPCA = systemic-to-pulmonary collateral artery; TCPC = total cavo-pulmonary connection; TGA = transposition of the great arteries.

^†Stenosis of the left pulmonary artery, subsequent surgery.

^§Additional occluder implanted for residual defect.

^¥Subsequent surgical resection.